#United States #Minneapolis #Rare Diseases #TeleRare Health #Virtual Consultation

TeleRare Health Launches Virtual Genomic Consultations

In an innovative move that promises to transform healthcare delivery, TeleRare Health® has unveiled its Virtual Genomic Consult Service in Minnesota. This groundbreaking service is designed to assist both adult and pediatric patients who are struggling to obtain diagnoses for rare and genetics-based diseases. Given that rare diseases affect over 30 million Americans, the timing of TeleRare's service is both crucial and timely.

The U.S. Department of Health and Human Services defines a rare disease as one that affects fewer than 200,000 Americans, and the National Institutes of Health (NIH) reports that approximately 10,000 such diseases exist. Patients often endure lengthy and complicated diagnostic journeys, necessitating specialized genetic testing, which can be a daunting task for affected families.

TeleRare Health's Virtual Genomic Consultations are designed to simplify this process. According to the company's President, Patti Engel, the service breaks down the complexities of diagnosis and treatment options, enabling healthcare professionals to provide individual and customized recommendations. This personalization stands out as a significant advantage in managing rare diseases, where the treatment landscape can be obscured by a myriad of choices.

With over 80% of rare diseases linked to genetic origins, selecting the appropriate genetic assay is often vital. The Virtual Genomic Consult Service tackles this challenge head-on by helping patients understand the precise costs associated with various assays, including Whole Exome Sequencing (WES).

Austin Letcher, Chief Operations Officer of TeleRare Health, notes that patients with rare diseases frequently encounter the dilemma of whether an FDA-approved medication exists for their condition. The service aims to navigate these complex scenarios, guiding patients through their options and focusing on practical, evidence-based paths to improved outcomes.

Scheduling a telehealth appointment through TeleRare Health is both straightforward and flexible, with availability often within the same week. This convenience holds the potential for accelerated diagnosis and treatment initiation, pivotal factors in managing rare diseases effectively.

The overarching vision of TeleRare Health is to establish itself as the leading virtual care provider for rare and genomic conditions, not just in Minnesota, but across the United States. The company is committed to ensuring that all patients have access to cutting-edge diagnostic processes and expert treatment options. As they focus on optimizing the patient experience through innovative telehealth solutions, TeleRare Health aspires to become a cornerstone in the realm of genetic testing and personalized medicine.

To date, TeleRare Health has already made waves in the healthcare landscape, winning the Early-Stage Innovation award at the Bear Institute PACK competition. This accolade highlights their commitment to enhancing pediatric digital health and improving care quality for young patients.

As healthcare increasingly embraces digital transformation, TeleRare Health stands as a beacon for patients grappling with rare genetic disorders, illuminating the path toward expedited diagnostics and individualized care.

For more information about TeleRare Health and their offerings, interested parties can visit their website at www.telerarehealth.com or contact them directly at their press contact email, [email protected], or call 651-994-0510.